Andre Stamm
14Patents
10h-index
6Co-inventors
61Inventor score
Filing activity: Oct 1, 1992 → Mar 21, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6117453A | Solid compositions containing polyethylene oxide and an active ingredient | Human Necessities | 113 | Expired |
| US5725872A | Composition for foams, notably rectal foams, and foams thus obtained | Human Necessities | 96 | Expired |
| US6074670A | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | Human Necessities | 90 | Expired |
| US5830546A | Reservoir system for prolonged diffusion of an active principle | Emerging Cross-Sectional Technologies | 69 | Expired |
| US6589552B2 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | Human Necessities | 48 | Expired |
| US6277405A | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | Human Necessities | 33 | Expired |
| US6048547A | Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient | Human Necessities | 19 | Expired |
| US6652881B2 | Fenofibrate pharmaceutical composition having high bioavailability | Human Necessities | 14 | Expired |
| US5824341A | Composition providing selective release of an active ingredient | Human Necessities | 11 | Expired |
| US7037529B2 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | Human Necessities | 10 | Expired |
| US7041319B2 | Fenofibrate pharmaceutical composition having high bioavailabilty | Human Necessities | 7 | Expired |
| US6596317B2 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | Human Necessities | 5 | Expired |
| US8329214B2 | Process for producing fenofibrate tablets | Human Necessities | 0 | Active |
| US8343540B2 | Process for producing fenofibrate tablets | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.